PDCD1 and liver cancer: At present, there are many clinical studies on lenvatinib and anti-PD-1 in the treatment of advanced liver cancer malignancies, such as NCT02579616 (21), NCT03006926 (14), NCT04044313 (22), NCT03895970 (16).